Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Vaccine

• Publication date

  2012-05-21

• Fields of study

  Biology, Medicine, Engineering

• Identifiers
  DOI 10.1016/j.vaccine.2012.03.025PMID 22449422PMCID PMC3595159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reverse genetics plasmid for cloning unstable influenza A virus gene segments.

  2011cited by this paper
• Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children.

  2011cited by this paper
• A mutation in the receptor binding site enhances infectivity of 2009 H1N1 influenza hemagglutinin pseudotypes without changing antigenicity.

  2010cited by this paper
• A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children.

  2010cited by this paper
• Significant Impact of Sequence Variations in the Nucleoprotein on CD8 T Cell-Mediated Cross-Protection against Influenza A Virus Infections

  2010cited by this paper
• Alternative Live-Attenuated Influenza Vaccines Based on Modifications in the Polymerase Genes Protect against Epidemic and Pandemic Flu

  2010cited by this paper
• NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets.

  2010cited by this paper
• Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses

  2010cited by this paper
• The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults

  2010cited by this paper
• PB2 Residue 158 Is a Pathogenic Determinant of Pandemic H1N1 and H5 Influenza A Viruses in Mice

  2010cited by this paper
• Modifications in the Polymerase Genes of a Swine-Like Triple-Reassortant Influenza Virus To Generate Live Attenuated Vaccines against 2009 Pandemic H1N1 Viruses

  2010cited by this paper
• Generation of Live Attenuated Novel Influenza Virus A/California/7/09 (H1N1) Vaccines with High Yield in Embryonated Chicken Eggs

  2009cited by this paper
• Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.

  2009cited by this paper
• Optimizing Viral Protein Yield of Influenza Virus Strain A/Vietnam/1203/2004 by Modification of the Neuraminidase Gene

  2009cited by this paper
• Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population

  2009cited by this paper
• In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses

  2009cited by this paper
• Influenza virus CTL epitopes, remarkably conserved and remarkably variable.

  2009cited by this paper
• Whole Genome Transcriptional Analysis of the Early Immune Responses Induced By Live Attenuated and Inactivated Influenza Vaccines in Young Children

  2009cited by this paper
• T-Cell Tolerance for Variability in an HLA Class I-Presented Influenza A Virus Epitope

  2009cited by this paper
• Single-Reaction Genomic Amplification Accelerates Sequencing and Vaccine Production for Classical and Swine Origin Human Influenza A Viruses

  2009cited by this paper
• Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses

  2008cited by this paper
• Cross-Recognition of Avian H5N1 Influenza Virus by Human Cytotoxic T-Lymphocyte Populations Directed to Human Influenza A Virus

  2008cited by this paper
• Growth Determinants for H5N1 Influenza Vaccine Seed Viruses in MDCK Cells

  2008cited by this paper
• Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.

  2008cited by this paper
• An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines

  2008cited by this paper
• A New Generation of Modified Live-Attenuated Avian Influenza Viruses Using a Two-Strategy Combination as Potential Vaccine Candidates

  2007cited by this paper
• Live attenuated versus inactivated influenza vaccine in infants and young children.

  2007cited by this paper
• 1918 Influenza: the Mother of All Pandemics

  2006cited by this paper
• Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections

  2006cited by this paper
• Genetic Analysis of Influenza Virus NS1 Gene: a Temperature-Sensitive Mutant Shows Defective Formation of Virus Particles

  2005cited by this paper
• Imparting Temperature Sensitivity and Attenuation in Ferrets to A/Puerto Rico/8/34 Influenza Virus by Transferring the Genetic Signature for Temperature Sensitivity from Cold-Adapted A/Ann Arbor/6/60

  2004cited by this paper
• Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.

  2004cited by this paper
• Introduction of a Temperature-Sensitive Phenotype into Influenza A/WSN/33 Virus by Altering the Basic Amino Acid Domain of Influenza Virus Matrix Protein

  2004cited by this paper
• Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines

  2004cited by this paper
• Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60.

  2003cited by this paper
• Principles Underlying the Development and Use of Live Attenuated Cold-Adapted Influenza A and B Virus Vaccines

  2002cited by this paper
• Sequence Variation in a Newly Identified HLA-B35-Restricted Epitope in the Influenza A Virus Nucleoprotein Associated with Escape from Cytotoxic T Lymphocytes

  2002cited by this paper
• Live attenuated vaccines against influenza; an historical review.

  2001cited by this paper
• Antigenic Drift in the Influenza A Virus (H3N2) Nucleoprotein and Escape from Recognition by Cytotoxic T Lymphocytes

  2000cited by this paper
• Generation of influenza A viruses entirely from cloned cDNAs.

  1999cited by this paper
• The development of live attenuated cold‐adapted influenza virus vaccine for humans

  1999cited by this paper
• Genetically engineered live attenuated influenza A virus vaccine candidates

  1997cited by this paper
• An influenza A live attenuated reassortant virus possessing three temperature-sensitive mutations in the PB2 polymerase gene rapidly loses temperature sensitivity following replication in hamsters.

  1997cited by this paper
• Sequence comparisons of A/AA/6/60 influenza viruses: mutations which may contribute to attenuation.

  1996cited by this paper
• Sequential addition of temperature-sensitive missense mutations into the PB2 gene of influenza A transfectant viruses can effect an increase in temperature sensitivity and attenuation and permits the rational design of a genetically engineered live influenza A virus vaccine

  1995cited by this paper
• Evaluation of the genetic stability of the temperature-sensitive PB2 gene mutation of the influenza A/Ann Arbor/6/60 cold-adapted vaccine virus

  1994cited by this paper
• Rescue of an influenza A virus wild-type PB2 gene and a mutant derivative bearing a site-specific temperature-sensitive and attenuating mutation

  1993cited by this paper
• Molecular and biological changes in the cold-adapted "master strain" A/AA/6/60 (H2N2) influenza virus.

  1993cited by this paper
• Nuclear retention of M1 protein in a temperature-sensitive mutant of influenza (A/WSN/33) virus does not affect nuclear export of viral ribonucleoproteins

  1992cited by this paper
• Nucleotide sequence changes in the polymerase basic protein 2 gene of temperature-sensitive mutants of influenza A virus.

  1992influential reference
• Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults

  1990cited by this paper
• Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines

  1988cited by this paper
• Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2).

  1988influential reference
• Comparison of long‐term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine

  1985cited by this paper
• Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection.

  1984cited by this paper
• Production and Level of Genetic Stability of an Influenza A Virus Temperature-Sensitive Mutant Containing Two Genes with ts Mutations

  1982cited by this paper
• Genetic factors associated with loss of the temperature-sensitive phenotype of the influenza A/Alaska/77-ts-1A2 recombinant during growth in vivo.

  1981cited by this paper
• Adaptation and growth characteristics of influenza virus at 25 degrees c.

  1967cited by this paper
• Adaptation and Growth Characteristics of Influenza Virus at 25° C

  1967cited by this paper
• AN INTERESTING CASE IN WARD 6.

  1964cited by this paper
• Influenza : the Mother of All Pandemics

  year unknowncited by this paper
• Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children

  year unknowncited by this paper

• Molecular Genetics as the Leading‐Edge Approach in Driving the Development of Live Attenuated Vaccines

  2026cites this paper
• Synthetic biology-inspired development of live attenuated influenza vaccines

  2025cites this paper
• A live attenuated NS1-deficient vaccine candidate for cattle-origin influenza A (H5N1) clade 2.3.4.4.b viruses

  2025cites this paper
• Live-attenuated influenza virus vaccine strain with an engineered temperature-sensitive and genetically stable viral polymerase variant

  2025cites this paper
• Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines

  2023cites this paper
• Challenges and Progress in Designing Broad-Spectrum Vaccines Against Rapidly Mutating Viruses.

  2023cites this paper
• Comparative study of the biological properties of influenza А virus mutants obtained by site-specific mutagenesis and the live influenza reassortant vaccine variant

  2022cites this paper
• Examination of the Physics solution of COVID-19

  2022cites this paper
• Decoding the Role of Temperature in RNA Virus Infections

  2022cites this paper
• Исследование отдельных звеньев иммунной системы мышей, иммунизированных сайт-специфическими мутантами вируса гриппа

  2020cites this paper
• Why is temperature sensitivity important for the success of common respiratory viruses?

  2020cites this paper
• Study of the biological properties of attenuated variants of the virulent A/WSN/33 strain of influenza virus, obtained by the site-specific mutagenesis of PB2-gene

  2019cites this paper
• Включение сайт-специфических мутаций в РВ1-ген вирулентного штамма A/WSN/33 (H1N1) вируса гриппа А меняет его фенотипические характеристики

  2019cites this paper
• Inclusion of site-specific mutations in the PB1-gene of a virulent A/WSN/33 (H1N1) strain of influenza A virus changes its phenotypic characteristics

  2019cites this paper
• Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines

  2019cites this paper
• A Live Attenuated Influenza Vaccine Elicits Enhanced Heterologous Protection When the Internal Genes of the Vaccine Are Matched to Those of the Challenge Virus

  2019cites this paper
• Development of a novel equine influenza virus live-attenuated vaccine

  2018cites this paper
• Generation of a broadly reactive influenza H1 antigen using a consensus HA sequence.

  2018cites this paper
• Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine

  2018cites this paper
• Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.

  2017cites this paper
• [INCLUSION OF SITE-SPECIFIC MUTATIONS INTO CONSERVATIVE SEG- MENTS OF PA-GENE RESULTS IN ATTENUATION OF VIRULENT INFLUENZA VIRUS STRAIN A/WSN/33].

  2017cites this paper
• A live-attenuated influenza vaccine for H3N2 canine influenza virus.

  2017cites this paper
• Creation of live influenza vaccines with the use of site-specific mutagenesis

  2017cites this paper
• Interplay of PA-X and NS1 Proteins in Replication and Pathogenesis of a Temperature-Sensitive 2009 Pandemic H1N1 Influenza A Virus

  2017cites this paper
• Investigation of Efficiency of Site-Specific Mutants of the Influenza Virus in Homological and Heterological Control Infection

  2017cites this paper
• Avian influenza viruses that cause highly virulent infections in humans exhibit distinct replicative properties in contrast to human H1N1 viruses

  2016cites this paper
• Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus

  2016influential citation
• NS1 Protein Amino Acid Changes D189N and V194I Affect Interferon Responses, Thermosensitivity, and Virulence of Circulating H3N2 Human Influenza A Viruses

  2016cites this paper
• Codon Deletions in the Influenza A Virus PA Gene Generate Temperature-Sensitive Viruses

  2016cites this paper
• Особенности иммунного ответа мышей, иммунизированных различными типами кандидатов в живые гриппозные вакцины, на инфекцию, вызванную вирулентным штаммом вируса гриппа

  2016cites this paper
• Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists

  2016cites this paper
• Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine

  2016cites this paper
• Relating plaque morphology to respiratory syncytial virus subgroup, viral load, and disease severity in children

  2015cites this paper
• Temperature-Sensitive Mutants in the Influenza A Virus RNA Polymerase: Alterations in the PA Linker Reduce Nuclear Targeting of the PB1-PA Dimer and Result in Viral Attenuation

  2015cites this paper
• High-Throughput Identification of Loss-of-Function Mutations for Anti-Interferon Activity in the Influenza A Virus NS Segment

  2014cites this paper
• Universal Influenza B Virus Genomic Amplification Facilitates Sequencing, Diagnostics, and Reverse Genetics

  2014cites this paper
• Development of a Mouse-Adapted Live Attenuated Influenza Virus That Permits In Vivo Analysis of Enhancements to the Safety of Live Attenuated Influenza Virus Vaccine

  2014cites this paper
• The Temperature-Sensitive and Attenuation Phenotypes Conferred by Mutations in the Influenza Virus PB2, PB1, and NP Genes Are Influenced by the Species of Origin of the PB2 Gene in Reassortant Viruses Derived from Influenza A/California/07/2009 and A/WSN/33 Viruses

  2014cites this paper
• Asparagine Substitution at PB2 Residue 701 Enhances the Replication, Pathogenicity, and Transmission of the 2009 Pandemic H1N1 Influenza A Virus

  2013cites this paper
• Principles underlying rational design of live attenuated influenza vaccines

  2012cites this paper